Arnaud C. Zwygart
Geneve, GE 1206, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Protein-Linker Co-engineering for Broad-Spectrum Antiviral Development against Enveloped Viruses.
Journal: ACS materials letters
Published: October 28, 2025
Novel Wide-Spectrum Virucidal Lipid Nanoparticles.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: June 26, 2025
Influenza A(H1N1)pdm09 virus resistance to baloxavir, oseltamivir and sialic acid mimetics in single and dual therapies: Insights from human airway epithelia and murine models.
Journal: Antiviral research
Published: October 25, 2024
Development of Broad-Spectrum β-Cyclodextrins-Based Nanomaterials Against Influenza Viruses.
Journal: Journal of medical virology
Published: April 25, 2024
A Synthetic Multivalent Lipopeptide Derived from Pam3CSK4 with Irreversible Influenza Inhibition and Immuno-Stimulating Effects.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: September 04, 2023
Antiviral properties of trans-δ-viniferin derivatives against enveloped viruses.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 22, 2023
An anti-influenza combined therapy assessed by single cell RNA-sequencing.
Journal: Communications biology
Published: February 14, 2022
Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir.
Journal: Microorganisms
Published: February 24, 2021
Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro.
Journal: Scientific reports
Published: December 23, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026